pyrrolidine dithiocarbamate has been researched along with Ischemic Attack, Transient in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, C; Li, J; Sheng, W; Zuo, Z | 1 |
Goldsteins, G; Koistinaho, J; Nurmi, A; Pihlaja, R; Vartiainen, N; Yrjänheikki, J | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Ischemic Attack, Transient
Article | Year |
---|---|
Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia.
Topics: Amyloid beta-Peptides; Animals; Behavior, Animal; Brain; Ischemic Attack, Transient; Male; Maze Learning; Memory; Motor Activity; Pyrrolidines; Rats; Rats, Sprague-Dawley; Recovery of Function; Thiocarbamates | 2012 |
Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window.
Topics: Animals; Cells, Cultured; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Gerbillinae; Ischemic Attack, Transient; Male; Microglia; Neurons; Neuroprotective Agents; Neurotoxins; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Protein Transport; Pyrrolidines; Rats; Rats, Inbred SHR; Rats, Wistar; Thiocarbamates; Time Factors; Treatment Outcome | 2004 |